Welcome to the e-CCO Library!

P391: Differential use of vedolizumab in ulcerative colitis and Crohn's disease. Real life results from 2 tertiary referral centres in the United Kingdom
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kamperidis N.*1, Cavazza A.2, Wahed M.2, Arebi N.1

Created: Wednesday, 20 February 2019, 10:36 AM
P391: Gender differences in adalimumab continuation rates: Results of a Crohn’s disease cohort
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Lie*, J. Kreijne, J. van der Woude

Created: Friday, 22 February 2019, 9:49 AM
P391: The availability of anti-TNF agents is associated with reduced early surgical requirements in Crohn’s disease but not in ulcerative colitis. A nationwide study from the Eneida registry
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Guasch1, A. Clos2, I. Ordás3,4, V. García-Sánchez5, J.P. Gisbert4,6, C. Taxonera7, I. Vera8, M. Mínguez9, J. Guardiola10, A. López-Sanromán11, M. Rivero-Tirado12, P. Nos13, F. Gomollón4,14, A.Y. Carbajo15, R. de Francisco16, M.D. Martín-Arranz17, E. Garcia-Planella18, S. García-López19, L. de Castro20, X. Calvet4,21, R. Camargo22, M. Esteve4,23, B. Sicilia24, M. Andreu25, A. Macho26, M. Piqueras27, F. Bermejo28, A. Gutiérrez29, D. Busquets30, P. Martínez-Montiel31, J. Hinojosa32, J.L. Pérez-Calle33, L. Bujanda34, A. Rodríguez-Pérez35, R. Lorente36, N. Jiménez37, M. Navarro-Llavat38, J.L. Cabriada39, P. Camo40, M. Van Domselaar41, E. Rodríguez-González42, C. Rodríguez-Gutiérrez43, J.M. Huguet44, A.J. Lucendo45, F. Argüelles46, P. Almela47, O. Merino48, M. Calafat49, M. Ogueta50, M. Charro51, J. Llaó52, C. Muñoz53, L. Ramos54, Á. Abad55, Ó. Roncero56, M. Barreiro-de-Acosta57, E. Sesé58, M. Mañosa2,4, E. Domènech2,4*

Created: Thursday, 21 February 2019, 9:14 AM
P391: Unpacking the different popular diets for pediatric Crohn's disease - concerns around nutritional adequacy
Year: 2022
Source: ECCO'22
Authors: Carmody , E.(1);Haskett , J.(1);Parkinson-McGraw , L.(1);Grover , Z.(1);Martinez , A.(1);Rashid , M.(1);Otley MD MSc FRCPC, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P392: A mobile application to monitor Inflammatory Bowel Disease patients during intravenous biologic treatment: Results of a feasibility study
Year: 2021
Source: ECCO'21 Virtual
Authors: Van Erp, L.W.(1);Groenen, M.J.M.(1);Heida, W.(1);Wisse, J.(1);Roosenboom, B.(1);Wahab, P.J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P392: Body mass index has no effect on treatment response in Crohn's disease patients with moderate disease activity who receive adalimumab
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Soufleris*1, K. Fasoulas1, N. Kafalis1, G. Lazaraki1, D. Tzilves1

Created: Friday, 22 February 2019, 9:41 AM
P392: Comparison of dietary nutrient and food additive intake between patients with moderately active ulcerative colitis, healthy stool donors and the general Australian population
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Costello S.*1,2,3, Mashei C.3, Bryant R.2,3, Katsikeros R.3, Waters O.4, Makanyanga J.4, Hughes P.2, Conlon M.5, Roberts-Thomson I.1,2, Andrews J.2,3

Created: Wednesday, 20 February 2019, 10:36 AM
P392: Comprehensive video capsule endoscopy-based monitoring predicts short and long-term risk of disease flares in small bowel Crohn’s disease: A prospective cohort study
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Ben-Horin1*, A. Lahat1, M.M. Amitai2, E. Klang2, D. Yablecovitch1, S. Neuman1, N. Levhar1, L. Selinger1, M. Bubis1, O. Picard1, D. Turner3, S. Odes4, H. Yanai5, Y. Chowers6, I. Dotan5, U. Kopylov1, R. Eliakim1

Created: Thursday, 21 February 2019, 9:14 AM
P392: Risk factors for postoperative recurrence after ileocolic resection for Crohn's Disease: long-term results from a population-based cohort.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: van Renterghem, A.(1)*;van der Holst, A.(1);van Kuijk, S.(2);Pierik, M.(3);Belgers, E.(4);Romberg-Camps, M.(5);Jeuring, S.(3);Demandt, D.(1);Stassen, L.(1);
Created: Friday, 14 July 2023, 11:05 AM
P392: To study the prevalence of depression and anxiety in patients of Inflammatory Bowel Disease (IBD) and the efficacy of psychopharmacotherapy in these patients: A pilot study
Year: 2022
Source: ECCO'22
Authors: Patel, A.(1);Joshi, H.(1);Wagh, A.(1);Bhatt, C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P393 Patient and physician perspectives on the management of inflammatory bowel disease: Role of steroids in the context of biologic therapy
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Afzali1, A. Armuzzi2, Y. Bouhnik3, B. Bressler4, A. Hart5, D. Rubin6, M. Sans7, B. Siegmund8, D. Sninsky9

Created: Thursday, 30 January 2020, 10:12 AM
P393: Effect of filgotinib on anaemia in patients with Ulcerative Colitis in SELECTION
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Loveikyte, R.(1)*;de Haas, A.(2);Oortwijn, A.(3);Eskens, B.(3);Jamoul, C.(4);Muller, K.(4);van der Meulen-de Jong, A.(5);
Created: Friday, 14 July 2023, 11:05 AM
P393: Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for acute severe colitis.
Year: 2022
Source: ECCO'22
Authors: Veyrard, P.(1);Pellet, G.(2);Laharie, D.(2);Nachury, M.(3);juillerat, P.(4);Altwegg, R.(5);Nancey, S.(6);Fumery, M.(7);Allez, M.(8);Tran minh, M.L.(9);Roblin, X.(10);
Created: Friday, 11 February 2022, 3:52 PM
P393: Evaluation of pharmacokinetic profiles of SB2 as a biosimilar of reference infliximab
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Shin D., Kang J.W., Park S., Lee Y., Lee S.

Created: Wednesday, 20 February 2019, 10:36 AM
P393: Investigation of Crohn’s disease patients receiving anti-TNF α therapy after surgery for intestinal stenosis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

T. Kuriyama*, B. Iizuka, H. Kashiwagi, T. Hara, A. Ito, T. Omori, M. Yonezawa, K. Tokushige

Created: Friday, 22 February 2019, 9:49 AM
P393: Long-term prediction of infliximab response using CD-62L shedding assay: Longitudinal data from 5-year study in inflammatory bowel disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Macpherson1, F. Bravo2, P. Andrew1, E. Slack1, N. Patuto1, J. Cahenzli1, K.D. McCoy1, A.J. Macpherson2, P. Juillerat1,2*

Created: Thursday, 21 February 2019, 9:14 AM
P393: Outcome of treat to target strategy in paediatric patients with Crohn’s disease and ulcerative colitis on infliximab
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

D. Yerlioglu*1, L. Cococcioni1, A. ElZein1, S. Sider1, S. Chadokufa1, R. Buckingham1, N. Shah1, A. Ocholi1, O. Borrelli1, F. Kiparissi1

Created: Friday, 22 February 2019, 9:41 AM